Clinically, higher baseline levels of IL-6 and C-reactive protein predict faster eGFR decline and progression to end-stage renal disease in human CKD cohorts, and elevated circulating TNF receptors 1 and 2 have been shown to forecast ESRD in diabetic patients[50]. Here, IL6 is linked to stage 5 chronic kidney disease.